Mario Schlosser plans $18.2M Oscar Health sale
Oscar Health, Inc. (OSCR) is the issuer for a planned resale of shares under Rule 144 by Mario T. Schlosser.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Oscar Health, Inc. (OSCR) is the issuer for a planned resale of shares under Rule 144 by Mario T. Schlosser. A notice has been filed for the potential sale of 600,000 Class A shares of Oscar Health through Fidelity Brokerage Services LLC, with an indicated aggregate market value of $18,205,505.85 and reference outstanding Class A shares of 273,469,000 as of August 27, 2026 on the NYSE. The shares are to be sold following a stock option exercise on a cash basis.
Over the prior three months, Mario T. Schlosser reported additional Rule 144 sales of Oscar Health Class A shares, including 34,120 shares for proceeds of $748,633.08 on June 2, 2026, 1,027,398 shares for $30,183,414.00 on June 23, 2026, and 47,500 shares for $1,484,013.80 on July 1, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
Class A financial
aggregate market value financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Oscar Health, Inc. (OSCR)?
Who is acting for Mario T. Schlosser in the OSCR Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.